Cited by 26Circadian rhythm and melatoninSleep and related disordersAttention Deficit Hyperactivity Disorder

Delayed Sleep Phase Syndrome, ADHD, and Bright Light Therapy

Open access
Gruber, Reut, Grizenko, Natalie, Joober, Ridha·2007·The Journal of Clinical Psychiatry

Abstract

Article Abstract Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text. Sir: Accumulating evidence suggests that many children with attention-deficit/hyperactivity disorder (ADHD) have a primary sleep disorder that accounts for some of their behavioral dysregulation.1,2 Most previous reports have focused on the association between ADHD and sleep in children with sleep-disordered breathing or restless legs syndrome.3-8 Here, we present a case in which ADHD symptoms and delayed sleep phase syndrome (DSPS) were rapidly relieved with bright light therapy.†‹

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.v68n0221h

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 30 references couldn’t be matched to a known paper.

Research works printed but not linked: 27

  1. Zhong KX, Sweitzer DE, Hamer RM, et al. Comparison of quetiapine and risperidone in the treatment of schizophrenia: a randomized, double-blind, flexible-dose, 8-week study. J Clin Psychiatry 2006; 67:1093-1103
  2. Piaggio G, Elbourne DR, Altman DG, et al, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295: 1152-1160 REFERENCES
  3. Potkin SG, Gharabawi GM, Greenspan AJ, et al. A double-blind com- parison of risperidone, quetiapine and placebo in patients with schizo- phrenia experiencing an acute exacerbation requiring hospitalization. Schizophr Res 2006;85:254-265
  4. Zhong KX, Sweitzer DE, Hamer RM, et al. Comparison of quetiapine and risperidone in the treatment of schizophrenia: a randomized, double-blind, flexible-dose, 8-week study. J Clin Psychiatry 2006;67:1093-1103
  5. Piaggio G, Elbourne DR, Altman DG, et al. Reporting of noninferior- ity and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152-1160
  6. Beasley CM Jr, Sanger T, Satterlee W, et al. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology (Berl) 1996;124:159-167
  7. Breier A, Hamilton SH. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biol Psychiatry 1999;45:403-411
  8. Daniel DG, Zimbroff DL, Potkin SG, et al. Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Neuropsychopharmacology 1999;20:491-505
  9. Marder SR, Meibach RC. Risperidone in the treatment of schizophre- nia. Am J Psychiatry 1994;151:825-835
  10. Knegtering R, Castelein S, Bous H, et al. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol 2004;24:56-61
  11. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsy- chotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223
  12. Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine expe- rience with safety and tolerability (QUEST) study. Clin Ther 2001;23: 1839-1854
  13. Riedel M, Muller N, Strassnig M, et al. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci 2005;255:432-437
  14. Dennis E. Sweitzer, Ph.D. Arthur Lazarus, M.D., M.B.A. Martin Brecher, M.D., M.B.A. AstraZeneca Pharmaceuticals Wilmington, Delaware REFERENCES 1. Duggal HS, Mendhekar DN. High-dose aripiprazole in treatment- refractory schizophrenia [letter]. J Clin Psychiatry 2006;67:674-675
  15. Clarke LA, Lindenmayer JP, Kaushik S. Clozapine augmentation with aripiprazole for negative symptoms [letter]. J Clin Psychiatry 2006;67:675-676
  16. Ashton AK. Aripiprazole augmentation of clozapine in refractory schizophrenia [letter]. Psychiatry 2005 2005;2:18-19 REFERENCES
  17. Stern TA, Herman JB. Massachusetts General Hospital Psychiatry Update & Board Preparation, Second Edition. New York, NY: McGraw-Hill; 2004
  18. van Vliet IM, Westenberg HG, Den Boer JA. MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine: a double blind placebo controlled study. Psychopharmacology (Berl) 1993;112:483-489
  19. Seaman S. Seeing catatonia. J Neuropsychiatry Clin Neurosci 2005;17:558-559
  20. Koussa S, Nasnas R. Catatonia and parkinsonism due to extrapontine myelinolysis following rapid correction of hyponatremia: a case re- port. J Neurol 2003;250:103-105
  21. Koenig M, Camdessanche JP, Duband S, et al. Extrapontine myeli- nolysis of favorable outcome in a patient with autoimmune polyglan- dular syndrome. Rev Med Interne 2005;26:65-68
  22. Munoz Martinez MJ, de la Fuente Aguado J, Gonzalez Novoa MC, et al. Descriptive study of a pneumonia episode due to Legionella. Rev Clin Esp 2006;206:12-16
  23. Sabria M, Campins M. Legionnaires' disease: update on epidemiol- ogy and management options. Am J Respir Med 2003;2:235-243
  24. Plaschke M, Strohle A, Then Bergh F, et al. Neurologic and psychiat- ric symptoms of legionella infection: case report and overview of the clinical spectrum. Nervenarzt 1997;68:342-345
  25. Owens JA. The ADHD and sleep conundrum: a review. J Dev Behav Pediatr 2005;26:312-322
  26. Picchietti DL, Underwood DJ, Farris WA. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 1999;14: 1000-1007
  27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994

Cited by

Sorted by citations

Authors
Gruber, R., Grizenko, N., & Joober, R.
Affiliations
  • Janssen (Belgium) (BE)
  • Douglas Mental Health University Institute (CA)
Venue
The Journal of Clinical Psychiatry
Published
2007-02-15
Volume
68
Issue
02
Pages
337-338
ISSN
0160-6689 (ISSN-L)
OpenAlex
W1982712320
Cited by
26
References
30
Citations by year
2026: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 2 · 2015: 1 · 2013: 2
FWCI
0.95
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
AstraZeneca
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Keywords
delayed sleep phase syndrome, attention deficit hyperactivity disorder, bright light therapy, circadian rhythm sleep disorders, children, behavioral dysregulation, sleep disorders
MeSH terms
Attention Deficit Disorder with Hyperactivity, Child, Humans, Male, Phototherapy, Sleep Disorders, Circadian Rhythm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review